Newsletter
12 de June de 2019
Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes
ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:
(i) the cultivation of the cannabis spp. for medical and scientific purposes; and
(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.
For further information, click below to access our full newsletter.
Back
Share:
Last related news
5 de August de 2026
Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System
We have been closely monitoring the progress of Bill No. 2,210/2022, which proposes significant amendments to the Brazilian Industrial Property Law, Law … Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System
17 de July de 2026
New rules for “bets” in Brazil
In the context of the ongoing development of the regulated market, the legal framework governing fixed-odds betting (“bets”) has undergone significant updates … New rules for “bets” in Brazil
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents